VACCINES

Visão geral
Metrics
Identidade
Informação adicional documento
Ver todos

Qualis

A3

código do país

CH

tipo

journal

publicação venue de

A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus. 11:1005. 2023-01-01
Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment. 11:1. 2023-01-01
Assessment of the Interferon-lambda-3 polymorfism in tht anti body response to COVID-19 in older adults seropositive fot CNV. na:na. 2023-01-01
Assessment of the Interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. 11:480. 2023-01-01
Attitudes and Behaviors towards Vaccination in Portuguese Nursing Students. 11:847. 2023-01-01
Autoinflammation in Syndromic Hidradenitis Suppurativa: The Role of AIM2. 11:162. 2023-01-01
B-Cell Epitope Mapping of the Plasmodium falciparum Malaria Vaccine Candidate GMZ2.6c in a Naturally Exposed Population of the Brazilian Amazon. 11:446. 2023-01-01
COVID-19 Vaccination in Pediatrics: Was It Valuable and Successful?. 11:214-.. 2023-01-01
Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?. 11:208-.. 2023-01-01
Cellular and Humoral Immune Responses to Vaccination for COVID-19 Are Negatively Impacted by Senescent T Cells: A Case Report. 11:840. 2023-01-01
Central and Effector Memory Human CD4+ and CD8+ T Cells during Cutaneous Leishmaniasis and after In Vitro Stimulation with Leishmania (Viannia) braziliensis Epitopes. 11:1-13. 2023-01-01
Clinical Characteristics and Outcomes among Vaccinated and Unvaccinated Patients with Cardiovascular Disease Who Were Hospitalized for COVID-19 in Brazil: Retrospective Cohort. 11:861. 2023-01-01
Covid-19 in a Pre-Omicron Era: a Cross-Sectional Immuno-Epidemical and Genomic Evaluation. 11:272. 2023-01-01
Decreased Expression of CD314 by NK Cells Correlates with Their Ability to Respond by Producing IFN-γ after BCG Moscow Vaccination and Is Associated with Distinct Early Immune Responses. 11:1-1314. 2023-01-01
Degron Pathways and Leishmaniasis: Debating Potential Roles of Leishmania spp. Proteases Activity on Guiding Hosts Immune Response and Their Relevance on The De-velopment of Vaccines.. 11:103090. 2023-01-01
Degron Pathways and Leishmaniasis: Debating Potential Roles of Leishmania spp. Proteases Activity on Guiding Hosts Immune Response and Their Relevance to the Development of Vaccines. 11:1015. 2023-01-01
Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines. 11:1222. 2023-01-01
Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico. 11:842. 2023-01-01
Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice. 11:73. 2023-01-01
Evaluation of the Association of Recombinant Proteins NanH and PknG from Corynebacterium pseudotuberculosis Using Different Adjuvants as a Recombinant Vaccine in Mice. 11:519. 2023-01-01
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees. 11:1183. 2023-01-01
Identification of immunodominant proteins of the 'Leishmania (Viannia) naiffi' sub proteome as pan specific vaccine targets against leishmaniasis. 11:1129. 2023-01-01
Incipient Parallel Evolution of SARS-CoV-2 Deltacron Variant in South Brazil. 11:212-9. 2023-01-01
Inequalities in Immunization against Maternal and Neonatal Tetanus: A Cross-Sectional Analysis of Protection at Birth Coverage Using Household Health Survey Data from 76 Countries. 11:752. 2023-01-01
Knowledge, Attitudes and Practices toward Dengue Fever, Vector Control, and Vaccine Acceptance Among the General Population in Countries from Latin America and Asia Pacific: A Cross-Sectional Study (GEMKAP). 11:575. 2023-01-01
Levels of Neutralizing Antibodies against SARS-CoV-2 in Mothers and Neonates after Vaccination during Pregnancy. 11:620-22. 2023-01-01
Low vaccine coverage and factors associated with incomplete childhood immunization in racial/ethnic minorities and rural groups, Central Brazil. 11:1-849. 2023-01-01
Misinformation about the COVID-19 Vaccine in Online Catholic Media. 11:1054-1077. 2023-01-01
Mortality and Associated Factors in Patients with COVID-19: Cross-Sectional Study. 11:71. 2023-01-01
Nanomedicine as a Potential Tool against Monkeypox. 11:428. 2023-01-01
Parental Justifications for Not Vaccinating Children or Adolescents against Human Papillomavirus (HPV). 11:506. 2023-01-01
Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms. 11:1. 2023-01-01
Polymeric delivery systems as a potential vaccine against visceral leishmaniasis: formulation development and immunogenicity. 11:1-1315. 2023-01-01
Prevalence, Risk Factors and Vaccine Response against Hepatitis B in People Aged 50 Years or Older. 11:597-612. 2023-01-01
RNA Vaccines: Yeast as a Novel Antigen Vehicle. 11:1334. 2023-01-01
Seroprevalence of SARS-CoV-2 and Vaccination Coverage among Residents of a Lower-Middle-Class Population in the Federal District, Brazil. 11:916-930. 2023-01-01
Sph2(176-191) and Sph2(446-459): Identification of B-Cell Linear Epitopes in Sphingomyelinase 2 (Sph2), Naturally Recognized by Patients Infected by Pathogenic Leptospires. 11:359-359. 2023-01-01
The BCG Moreau Vaccine Upregulates In Vitro the Expression of TLR4, B7-1, Dectin-1 and EP2 on Human Monocytes. 11:86-96. 2023-01-01
The Trajectory of Brazilian Immunization Program between 1980 and 2018: From the Virtuous Cycle to the Vaccine Coverage Decline. 11:1189. 2023-01-01
The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection. 11:395-412. 2023-01-01
Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges. 8:1-14. 2023-01-01
Trends in Pneumococcal and Bacterial Meningitis in Brazil from 2007 to 2019. 11:1279. 2023-01-01
Using an Aluminum Hydroxide-Chitosan Matrix Increased the Vaccine Potential and Immune Response of Mice against Multi-Drug-Resistant Acinetobacter baumannii. 11:669-15. 2023-01-01
Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster. 11:111-14. 2023-01-01
Vaccinomics Approach for Multi-Epitope Vaccine Design against Group A Rotavirus Using VP4 and VP7 Proteins. 11:1-17. 2023-01-01
Yellow Fever Vaccine-Related Neurotropic Disease in Brazil Following Immunization with 17DD. 11:445. 2023-01-01
100 Years of BCG Immunization: Past, Present, and Future. 10:1743. 2022-01-01
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection. 10:1146-1168. 2022-01-01
A Systematic Review and a Meta-Analysis of the Yellow Fever Vaccine in the Elderly Population. 10:1-14. 2022-01-01
Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months Duration. 10:690-703. 2022-01-01
Adjuvant curdlan contributes to the immunization against Cryptococcus gattii infection in a mouse strain-specific manner. 10:1-26. 2022-01-01
Adults? Acceptance of COVID-19 Vaccine for Children in Selected Lower- and Middle-Income Countries. 10:11. 2022-01-01
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives. 10:802. 2022-01-01
Beliefs and Sociodemographic and Occupational Factors Associated with Vaccine Hesitancy among Health Workers. 10:12-16. 2022-01-01
Brazilian Adults’ Attitudes and Practices Regarding the Mandatory COVID-19 Vaccination and Their Hesitancy towards Childhood Vaccination. 10:1-11. 2022-01-01
COVID-19 Vaccines Confer Protection in Hospitalized Pregnant and Postpartum Women with Severe COVID-19: A Retrospective Cohort Study. 10:749-759. 2022-01-01
COVID-19: Impact of Original, Gamma, Delta, and Omicron Variants of SARS-CoV-2 in Vaccinated and Unvaccinated Pregnant and Postpartum Women. 10:2172. 2022-01-01
Determinants of COVID-19 Vaccine Acceptance among Dental Professionals: A Multi-Country Survey. 10:1614. 2022-01-01
Developing a Feline Immunodeficiency Virus Subtype B Vaccine Prototype Using a Recombinant MVA Vector. 10:1717-1730. 2022-01-01
Development and Qualification of an Antigen Integrity Assay for a Plasmodium falciparum Malaria Transmission Blocking Vaccine Candidate, Pfs230. 10:1628. 2022-01-01
Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women. 10:1724-1724. 2022-01-01
Economic-Related Inequalities in Zero-Dose Children: A Study of Non-Receipt of Diphtheria-Tetanus-Pertussis Immunization Using Household Health Survey Data from 89 Low- and Middle-Income Countries. 10:633. 2022-01-01
Efficacy and Safety of Native and Recombinant Zona Pellucida Immunocontraceptive Vaccines Formulated with Non-Freund?s Adjuvants in Donkeys. 10:1999. 2022-01-01
Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit. 10:356. 2022-01-01
Exposition to Chlamydia trachomatis infection in individuals who are newly diagnosed with HIV and antiretroviral-naïve from Belém, Northern Brazil. 10:1719-1726. 2022-01-01
Exposure of Zero-Dose Children to Multiple Deprivation: Analyses of Data from 80 Low- and Middle-Income Countries. 10:1568. 2022-01-01
Exposure to Chlamydia trachomatis Infection in Individuals Who Are Newly Diagnosed with HIV and Antiretroviral-Naïve from Belém, Northern Brazil. 10:1. 2022-01-01
Gender-Related Inequality in Childhood Immunization Coverage: A Cross-Sectional Analysis of DTP3 Coverage and Zero-Dose DTP Prevalence in 52 Countries Using the SWPER Global Index. 10:988. 2022-01-01
Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis. 10:123. 2022-01-01
Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells. 10:1907. 2022-01-01
In Silico Designed Multi-Epitope Immunogen -Tpme-VAC/LGCM-2022- May Induce Both Cellular and Humoral Immunity against Treponema pallidum Infection. 10:1019. 2022-01-01
Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice.. 10:1-15. 2022-01-01
LAMP-1 Chimeric to HIV-1 p55Gag in the Immunization of Neonate Mice Induces an Early Germinal Center Formation and AID Expression. 10:1246. 2022-01-01
Low Genetic Polymorphism in the Immunogenic Sequences of Rhipicephalus microplus Clade C. 10:1909. 2022-01-01
Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination. 10:154. 2022-01-01
Nanoformulations with Leishmania braziliensis antigens triggered controlled parasite burden in vaccinated golden hamster (Mesocricetus auratus) against visceral leishmaniasis. 10:1-1. 2022-01-01
Out-of-Season Influenza during a COVID-19 Void in the State of Rio de Janeiro, Brazil: Temperature Matters. 10:821. 2022-01-01
Population-Based Analysis of the Immunoglobulin G Response to Different COVID-19 Vaccines in Brazil. 11:1-12. 2022-01-01
Potential Novel N-Glycosylation Patterns Associated with the Emergence of New Genetic Variants of PRRSV-2 in the U.S. 10:2021. 2022-01-01
Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors. 10:1437-1447. 2022-01-01
Prediction of Novel Drug Targets and Vaccine Candidates against Human Lice (Insecta), Acari (Arachnida), and Their Associated Pathogens. 10:8. 2022-01-01
Prone Positioning: A Safe and Effective Procedure in Pregnant Women Presenting with Severe Acute Respiratory Distress Syndrome.. 10:2182. 2022-01-01
Protease-Based Subunit Vaccine in Mice Boosts BCG Protection against Mycobacterium tuberculosis. 10:306-315. 2022-01-01
Recombinant BCG Expressing the Subunit 1 of Pertussis Toxin Induces Innate Immune Memory and Confers Protection against Non-Related Pathogens. 10:234. 2022-01-01
Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages. 10:831. 2022-01-01
Reduced Prevalence of Measles Antibodies in a Cohort of Brazilian Children under 15 Years of Age. 10:1570. 2022-01-01
Retrospective Cohort Study of COVID-19 in Patients of the Brazilian Public Health System with SARS-CoV-2 Omicron Variant Infection. 10:1504-1510. 2022-01-01
Successive pandemic waves with different virulent strains, and 2 the effects of vaccination for SARS-CoV-2. 10:343-360. 2022-01-01
The Association of Bacterin and Recombinant Proteins Induces a Humoral Response in Sheep against Caseous Lymphadenitis. 10:1-12. 2022-01-01
The BCG Moreau vaccine upregulates in vitro the expression of TLR4, B7-1, Dectin-1 and EP2 on human monocytes. 122:1-21. 2022-01-01
The Effect of Being Pregnant during Respiratory Pandemics: A Comparison between 2009/10 Flu and 2020/21 COVID-19 Pandemic in Brazil. 10:1202. 2022-01-01
The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination. 10:696. 2022-01-01
The Efficacy of a Trivalent Inactivated Salmonella Vaccine Combined with the Live S. Gallinarum 9R Vaccine in Young Layers after Experimental Infections with S. Enteritidis, S. Typhimurium, and S. Infantis. 10:1113. 2022-01-01
The Influenza Vaccine May Protect Pregnant and Postpartum Women against Severe COVID-19. 10:206. 2022-01-01
The Role of COVID-19 Vaccinal Status in Admitted Children during OMICRON Variant Circulation in Rio de Janeiro, City-Preliminary Report. 10:619. 2022-01-01
The importance of vaccination in the context of the COVID-19 pandemic: a brief update regarding the use of vaccines. 10:591. 2022-01-01
Vaccines against Emerging and Neglected Infectious Diseases: An Overview. 10:1385. 2022-01-01
A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC. 9:1-19 / 1116-2021. 2021-01-01
Assessment of Anti-SARS-CoV-2 Antibodies Post-Coronavac Vaccination in the Amazon Region of Brazil. 9:1169-8. 2021-01-01
Association of Polymorphisms in the Glutathione S-Transferase Theta-1 Gene with Cirrhosis and Hepatocellular Carcinoma in Brazilian Patients with Chronic Hepatitis C. -:-. 2021-01-01
Bacillus Calmette-Guérin Immunotherapy for Cancer. 9:439. 2021-01-01
COVID-19 Research: Lessons from Non-Human Primate Models. 9:886. 2021-01-01
COVID-19 Vaccine Acceptability and Its Determinants in Mozambique: An Online Survey. 9:828. 2021-01-01
Changes in Serum Biomarkers of Oxidative Stress in Cattle Vaccinated with Tick Recombinant Antigens: A Pilot Study. 9:5. 2021-01-01
Clinical Applications and Immunological Aspects of Electroporation-Based Therapies. 9:727. 2021-01-01
Comparative Evaluation of Immune Responses and Protection of Chitosan Nanoparticles and Oil-Emulsion Adjuvants in Avian Coronavirus Inactivated Vaccines in Chickens. 9:1457. 2021-01-01
CpG-ODN Signaling via Dendritic Cells-Expressing MyD88, but Not IL-10, Inhibits Allergic Sensitization. 1:1. 2021-01-01
Determinants of COVID-19 Vaccine Hesitancy in Portuguese-speaking countries: a Structural equations modeling approach. 9:1-1167. 2021-01-01
Elderly Subjects Supplemented with L-Glutamine Shows an Improvement of Mucosal Immunity in the Upper Airways in Response to Influenza Virus Vaccination. 9:107. 2021-01-01
Epitope Mapping of the Diphtheria Toxin and Development of an ELISA-Specific Diagnostic Assay. 9:313. 2021-01-01
Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries. 9:515. 2021-01-01
Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols. 9:408. 2021-01-01
Finding Children with High Risk of Non-Vaccination in 92 Low- and Middle-Income Countries: A Decision Tree Approach. 9:646. 2021-01-01
Global Trends and Correlates of COVID-19 Vaccination Hesitancy: Findings from the iCARE Study. 9:661. 2021-01-01
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine. 9:67. 2021-01-01
ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines. 9:1350. 2021-01-01
Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19. 9:478. 2021-01-01
Major Complex Trait for Early De Novo Programming `CoV-MAC-TED? Detected in Human Nasal Epithelial Cells Infected by Two SARS-CoV-2 Variants Is Promising to Help in Designing Therapeutic Strategies. 9:1399. 2021-01-01
Multiepitope proteins for the differential detection of IgG antibodies against RDB of the spike protein and non-RDB regions of SARS-CoV-2. 9:986. 2021-01-01
Perception of COVID-19 Vaccination Amongst Physicians in Colombia. 9:287. 2021-01-01
Perspectives on new vaccines against arboviruses using Insect-specific viruses as platforms. 9:263-273. 2021-01-01
Phylogenetic Structure and Sequential Dominance of Sub-Lineages of PRRSV Type-2 Lineage 1 in the United States. 9:608. 2021-01-01
Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies. 9:1338. 2021-01-01
Protection against different genotypes of Newcastle disease viruses (NDV) afforded by an adenovirus-vectored fusion protein and live NDV vaccines in chickens. 9:182. 2021-01-01
Protective Effect of Nasal Colonisation with -cps/piaA and -cps/proABCStreptococcus pneumoniae Strains against Recolonisation and Invasive Infection. 9:261. 2021-01-01
Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis. 9:1166. 2021-01-01
SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center. 9:560. 2021-01-01
Staphylococcus aureus protection-related type 3 cell-mediated immune response elicited by recombinant proteins and GM-CSF DNA vaccine. 9:899-914. 2021-01-01
The Impact of an Inactivated Hepatitis A Vaccine with One Dose in Brazil: A Retrospective Time-Series. 9:407. 2021-01-01
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. 9:1345. 2021-01-01
The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis. 9:1101. 2021-01-01
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants. 9:1409. 2021-01-01
VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases. 9:220-228. 2021-01-01
Willingness to Get the COVID-19 Vaccine among Residents of Slum Settlements. 9:951-959. 2021-01-01
A DNA Vaccine Encoding Plasmodium falciparum PfRH5 in Cationic Liposomes for Dermal Tattooing Immunization. 8:619. 2020-01-01
A Durable Relationship: Respiratory Syncytial Virus Bronchiolitis and Asthma past Their Golden Anniversary. 8:201. 2020-01-01
Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs. 4:100048. 2020-01-01
Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli. 8:492. 2020-01-01
Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs. 8:115. 2020-01-01
Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis. 8:252-xxx. 2020-01-01
Chimeric Vaccines Designed by ImmunoinformaticsActivated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis. 8:1. 2020-01-01
Combined Exercise Training and l-Glutamine Supplementation Enhances Both Humoral and Cellular Immune Responses after Influenza Virus Vaccination in Elderly Subjects. 8:685. 2020-01-01
Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2. 8:472. 2020-01-01
Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1. 8:565-x. 2020-01-01
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis. 8:289-309. 2020-01-01
NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development. 8:394. 2020-01-01
Natural Self-Ligand Gamma Delta T Cell Receptors (γδTCRs) Insight: The Potential of Induced IgG. 8:436-451. 2020-01-01
Phase I and II Clinical Trial Comparing the LBSap, Leishmune®, and Leish-Tec® Vaccines against Canine Visceral Leishmaniasis. 8:690-xxx. 2020-01-01
Pre-Erythrocytic Vaccines against Malaria. 8:400. 2020-01-01
Protective Malaria Vaccine in Mice Based on the Plasmodium vivax Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein. 8:1-19. 2020-01-01
Quantitative Proteomics Identifies Metabolic Pathways Affected by Babesia Infection and Blood Feeding in the Sialoproteome of the Vector Rhipicephalus bursa. 8:91-91. 2020-01-01
Simple Nanoparticles from the Assembly of Cationic Polymer and Antigen as Immunoadjuvants. 8:105. 2020-01-01
Towards an Effective, Rational and Sustainable Approach for the Control of Cattle Ticks in the Neotropics. 8:9. 2020-01-01
Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines. 8:161. 2020-01-01
Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus. 8:116. 2020-01-01

tem uma área de assunto

publisher

MDPI

is open access

True invalid format

is in DOAJ

True invalid format